Arterial Stiffness and Blood Pressure

NARecruitingINTERVENTIONAL
Enrollment

228

Participants

Timeline

Start Date

May 1, 2025

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2028

Conditions
HypertensionVascular StiffnessAging
Interventions
OTHER

Blood pressure treatment algorithm

Single or combination antihypertensive therapy as needed: 1) amlodipine (2.5-10 mg), 2) telmisartan (20-80 mg) or losartan (25-100 mg), 3) chlorthalidone (6.25-25 mg), or 4) spironolactone (12.5-50 mg). a two-drug regimen with either amlodipine + chlorthalidone or telmisartan + chlorthalidone will be initiated following randomization. If a diuretic is contraindicated, amlodipine + telmisartan will be initiated. For those over 75 years, either amlodipine or telmisartan will be initiated at baseline if SBP is \<140 mmHg. In the standard treatment group (SBP goal of \< 140 mmHg), participants will either be prescribed amlodipine or telmisartan/losartan as initial therapy. If \>3 medications are necessary to reach the intensive goal and no first line options remain, potassium sparing diuretics or direct vasodilators will be considered.

Trial Locations (3)

35233-1927

ENROLLING_BY_INVITATION

Birmingham VA Medical Center, Birmingham, AL, Birmingham

37212-2637

ENROLLING_BY_INVITATION

Tennessee Valley Healthcare System Nashville Campus, Nashville, TN, Nashville

53705-2254

RECRUITING

William S. Middleton Memorial Veterans Hospital, Madison, WI, Madison

All Listed Sponsors
collaborator

VA Tennessee Valley Health Care System

FED

collaborator

Birmingham, Alabama VA Medical Center

FED

collaborator

The Lundquist Institute

UNKNOWN

collaborator

University of Wisconsin, Madison

OTHER

lead

VA Office of Research and Development

FED